FineMedix Co

FineMedix Co Current Liabilities

The Current Liabilities of FineMedix Co (387570.KQ) as of Nov 2, 2026 is 140.47 M KRW. In the previous year, Current Liabilities was 595.90 M KRW — a change of -76.43% (lower).

Current Liabilities

140.47 MKRW

YoY

-76.43%

Last updated:

Current Liabilities of FineMedix Co is 2025 140.47 M KRW. Current Liabilities of FineMedix Co was 2024 595.90 M KRW. It decreases by -76.43% lower compared to the previous year.

The FineMedix Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2022
2.40 B KRW
Jan 1, 2023
663.06 M KRW
Jan 1, 2024
595.90 M KRW
Jan 1, 2025
140.47 M KRW
The FineMedix Co Current Liabilities history
YEARCurrent LiabilitiesYoY
140.47 MKRW-76.43%
595.90 MKRW-10.13%
663.06 MKRW-72.32%
2.40 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FineMedix Co Stock analysis

What does FineMedix Co do? FineMedix Co Ltd generates revenue through the manufacturing and sales of microinvasive medical devices, including therapeutic and diagnostic endoscopes. The company also offers endoscopic surgery devices such as knives, injectors, baskets, endoscopic clips, and snares for endoscopic submucosal dissection and endoscopic mucosal resection. These products are sold to healthcare providers and medical facilities specializing in minimally invasive procedures. The company's primary focus on endoscopic devices positions it within the medical devices manufacturing sector, targeting hospitals and clinics that require advanced tools for minimally invasive surgeries. FineMedix Co Ltd's product portfolio supports both diagnostic and therapeutic applications in endoscopic procedures, catering to the growing demand for less invasive surgical techniques. As a Korea-based firm, FineMedix Co Ltd serves the domestic market with its specialized medical equipment. The company's offerings are designed to meet the needs of medical professionals performing endoscopic surgeries, ensuring precision and efficiency in procedures such as ESD and EMR. FineMedix Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about FineMedix Co stock

Current Liabilities of FineMedix Co is 140.47 M KRW in 2025.

Current Liabilities of FineMedix Co changed from 595.90 M KRW to 140.47 M KRW, representing a -76.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities FineMedix Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's FineMedix Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — FineMedix Co

All Key Metrics — FineMedix Co